In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America. by Gales AC, Jones RN, Andrade SS, Pereira AS and Sader HS published in Braz. J. Infect. Dis. 2005; 9 (5): 348-356